Advertisement
According to a final recommendation statement from the U.S. Preventive Services Task Force published in the Sept. 6 issue of the Journal of the American Medical Association

USPSTF Recommends Latent Tuberculosis Infection Screening

0
Screening for LTBI in persons at increased risk of infection provides moderate net benefit
For children with cystic fibrosis

Ultrashort Echo-Time MRI IDs Lung Abnormalities in CF

0
Strong correlations for CT and UTE MRI scores for pediatric CF patients for bronchiectasis, overall score
Patients with cancer have increased risks of iatrogenic and non-iatrogenic injuries shortly before and after cancer diagnosis

Risk of Injuries Up Around Period of Cancer Diagnosis

0
Increased risk of iatrogenic injuries, non-iatrogenic injuries before and after diagnosis of cancer
A new decision-making tool for doctors may help reduce unnecessary use of antibiotics in children with respiratory tract infection and cough

New Decision-Making Tool Can Cut Unnecessary Antibiotic Use

0
A drop of about 10 percent is possible, study authors suggest
Children using a combination long-acting beta agonist/steroid inhaler do not have any greater risk of harm than children using a steroid inhaler alone

Salmeterol + Fluticasone Deemed Safe for Childhood Asthma

0
FDA to review findings, researcher says

August 2016 Briefing – Pulmonology

0
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for August 2016. This roundup includes the latest...
Factors that are associated with exacerbation-prone asthma have been identified

Comorbidity Factors Identified for Exacerbation-Prone Asthma

0
Blood eosinophils, BMI, bronchodilator responsiveness tied to exacerbation frequency
Though a growing number of Americans are able to afford prescription medications

ACA Is Helping More Americans Afford Prescriptions

0
Improvement seen in all age levels, but millions still struggle with the cost of prescription drugs
For patients with heart failure with reduced ejection fraction

Sacubitril-Valsartan Reasonably Cost-Effective in Heart Failure

0
Cost of $47,053 per quality-adjusted life-year gained in base-case analysis
While treatment with continuous positive airway pressure reduces sleep apnea symptoms

Risk of Cardiovascular Events Not Reduced With CPAP Use

0
CPAP helps patients feel better, but does not appear to cut odds for cardiovascular events